[Design and study of new agents having antitubercular activity: the original compound perchlosone as a potent agent of etiotropic therapy for tuberculosis].
Studies dealing with the design of new antituberculous agents based on goal-oriented synthesis have provided the agent Perchlosone which is similar to isoniazid and rifampicin, produces in tuberculostatic activity against sensitive laboratory cultured mycobacteria, produces an inhibitory action on polyresistant clinical strains. Experiments on animals (mice, rabbits) with experimental tuberculosis have established that Perchlosone and isoniazid have equal therapeutical properties, and the former shows a synergist interaction with rifampicin, has neither mutagenic activity nor negative effects on immunity and the surfactant system of the lung.
Vinogradova
T I
TI
Aleksandrova
A E
AE
Antonenkova
E V
EV
Elokhina
V N
VN
Nakhmanovich
A S
AS
D000818:Animals; D000995:Antitubercular Agents / Q000138:chemical synthesis / Q000627:therapeutic use*; D015195:Drug Design; D004357:Drug Synergism; D006801:Humans; D051379:Mice; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D011725:Pyridines / Q000737:chemistry / Q000627:therapeutic use*; D011817:Rabbits; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000382:microbiology
D000995:Antitubercular Agents; D011725:Pyridines
Konstruirovanie i issledovanie novykh veshchestv, obladaiushchikh protivotuberkuleznoĭ aktivnost'iu: original'noe soedinenie perkhlozon kak vozmozhnoe sredstvo étiotropnoĭ terapii tuberkuleza.